Skip to main content

Table 1 Characteristics of HIV-infected patients. Baseline clinical and demographic characteristics of HIV-infected patients, who completed the study (n = 79)

From: Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses

Variables

Vaccine 10 μg

Vaccine 40 μg

p

No. patients (%)

39 (49.3)

40 (50.7)

-

Gender male – No. (%)

27 (69.2)

29 (72.5)

0.749

Mean age (years ± s.d.)

35.6 ± 8.12

34.1 ± 7.6

0.378

HIV exposure – No. (%)

   

Heterosexual

18 (45%)

16 (41%)

0.721

Homo or bisexual

22 (55%)

23 (59%)

 

Diagnosis of HIV (months ± s.d.)

40.6 ± 35.4

40.2 ± 32.65

0.960

Mean CD4 count (cel/mm3 ± s.d.)

245 ± 217.9

225.45 ± 189.7

0.671

CD4 cel/mm3 / No. (%)

   

< 200

20 (51.3%)

21 (52.5%)

0.914

≥ 200

19 (48.8%)

19 (47.5%)

 

Viral load (copies/mL)

75,187 ± 153,305

67,335 ± 112,742

0.811

Viral load (copies/mL) – No. (%)

   

≤ 400

6 (20%)

9 (25%)

0.860

400 – ≤ 20,000

11 (36.6%)

11 (30.6%)

 

≥ 20,000

13 (43.3%)

16 (44.4%)

 

AIDS-defining illness – No. (%)

17 (43.6)

10 (25)

0.082

Treatment with HAART* – No. (%)

22 (56.4)

29 (72.5)

0.135

PI

20 (51.2)

23 (57.5)

 

NNRTI

1 (2.6)

4 (10)

 

PI + NNRTI or 3 NRTI

1 (2.6)

2 (5)

 
  1. PI: Protease inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; NRTI: Nucleoside reverse transcriptase inhibitor.